Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014

Generics and Biologics 2014

24 Feb 2014 - 25 Feb 2014 - Mumbai, India

Bookmark and Share

The past decade has witnessed significant consolidation in the generic industry mostly because of patent expiry of large number of pharmaceutical innovator products. Given the tremendous pressure on both innovator and generic companies to maintain growth, this trend is likely to continue. This growth has also brought in stern competition amongst generic pharmaceutical companies in order to get a slice of pie out of the market. Innovation strategies, niche generics, cost reduction and reducing regulatory uncertainties are some of the topics to be deliberated for the success of the generic pharmaceutical industry. The Generics track of this event aims to bring together the experience of Pharmaceutical Industry professionals for achieving this objective.

Quality and structure of biologics is of utmost importance because of their dependency on extremely narrow specifications in manufacturing processes. This track on Biologics will focus on development of quality biologics on one hand and regulatory requirements and compliance issues, as well as expedited approval and market introduction of biosimilar competitors on the other hand.  Biosimilars or follow-on-biologics or subsequent entry biologics provide potential cost saving opportunities for drug manufacturers and therefore will be in the spotlight. 

This event is co-located with our 2nd international event on “QbD in Pharma Development” and an exhibition featuring latest technology and equipment in formulation development, bioanalysis and software for QbD studies. Registered delegates will have unrestricted access to all the co-located events and exhibition.

Agenda Tracks:
•    Generics - Expanding the Base: Improving Business and Regulatory Predictability for Complex, Niche Generics
•    Biologics - Quality Biologics for Ensuring Regulatory and Market Success

Call for Posters
You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 19 January 2014

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos